[日本語] English
万見
- PDB-1ter: SOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC... -

+
データを開く


IDまたはキーワード:

読み込み中...

-
基本情報

登録情報
データベース: PDB / ID: 1ter
タイトルSOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC RESONANCE AND DISTANCE GEOMETRY
要素TERTIAPIN
キーワードTOXIN
機能・相同性Honey bee toxin / Honey bee toxin / toxin activity / calmodulin binding / extracellular region / Tertiapin
機能・相同性情報
生物種Apis mellifera (セイヨウミツバチ)
手法溶液NMR
データ登録者Xu, X. / Nelson, J.W.
引用ジャーナル: Proteins / 年: 1993
タイトル: Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry.
著者: Xu, X. / Nelson, J.W.
履歴
登録1994年4月8日処理サイト: BNL
改定 1.01995年2月7日Provider: repository / タイプ: Initial release
改定 1.12008年3月24日Group: Version format compliance
改定 1.22011年7月13日Group: Version format compliance
改定 1.32017年11月29日Group: Derived calculations / Other
カテゴリ: pdbx_database_status / pdbx_struct_assembly ...pdbx_database_status / pdbx_struct_assembly / pdbx_struct_oper_list / struct_conf / struct_conf_type
Item: _pdbx_database_status.process_site

-
構造の表示

構造ビューア分子:
MolmilJmol/JSmol

ダウンロードとリンク

-
集合体

登録構造単位
A: TERTIAPIN


分子量 (理論値)分子数
合計 (水以外)2,4641
ポリマ－2,4641
非ポリマー00
水00
1


  • 登録構造と同一
  • 登録者が定義した集合体
タイプ名称対称操作数
identity operation1_5551
Atom site foot note1: LEU 2 - CYS 3 MODEL 1 OMEGA = 218.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: ILE 8 - ILE 9 MODEL 1 OMEGA = 142.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: PRO 11 - HIS 12 MODEL 1 OMEGA = 225.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: HIS 12 - MET 13 MODEL 1 OMEGA = 144.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: LYS 17 - CYS 18 MODEL 1 OMEGA = 134.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: GLY 19 - LYS 20 MODEL 1 OMEGA = 234.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: LYS 20 - LYS 21 MODEL 1 OMEGA = 228.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: ARG 7 - ILE 8 MODEL 2 OMEGA = 213.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: PRO 11 - HIS 12 MODEL 2 OMEGA = 220.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: HIS 12 - MET 13 MODEL 2 OMEGA = 149.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: LYS 17 - CYS 18 MODEL 2 OMEGA = 131.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: GLY 19 - LYS 20 MODEL 2 OMEGA = 235.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: LYS 20 - LYS 21 MODEL 2 OMEGA = 231.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: LEU 2 - CYS 3 MODEL 3 OMEGA = 221.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: ASN 6 - ARG 7 MODEL 3 OMEGA = 148.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: ILE 9 - ILE 10 MODEL 3 OMEGA = 214.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: PRO 11 - HIS 12 MODEL 3 OMEGA = 227.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: HIS 12 - MET 13 MODEL 3 OMEGA = 147.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: LYS 17 - CYS 18 MODEL 3 OMEGA = 140.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: GLY 19 - LYS 20 MODEL 3 OMEGA = 222.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: LEU 2 - CYS 3 MODEL 4 OMEGA = 227.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: ASN 6 - ARG 7 MODEL 4 OMEGA = 145.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: ILE 8 - ILE 9 MODEL 4 OMEGA = 146.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: PRO 11 - HIS 12 MODEL 4 OMEGA = 225.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: HIS 12 - MET 13 MODEL 4 OMEGA = 141.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: LYS 17 - CYS 18 MODEL 4 OMEGA = 138.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: GLY 19 - LYS 20 MODEL 4 OMEGA = 237.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: LYS 20 - LYS 21 MODEL 4 OMEGA = 228.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: LEU 2 - CYS 3 MODEL 5 OMEGA = 215.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: ILE 8 - ILE 9 MODEL 5 OMEGA = 147.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: PRO 11 - HIS 12 MODEL 5 OMEGA = 234.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: CYS 14 - TRP 15 MODEL 5 OMEGA = 140.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: LYS 17 - CYS 18 MODEL 5 OMEGA = 141.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: GLY 19 - LYS 20 MODEL 5 OMEGA = 220.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: LYS 20 - LYS 21 MODEL 5 OMEGA = 148.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: LEU 2 - CYS 3 MODEL 6 OMEGA = 210.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: ASN 6 - ARG 7 MODEL 6 OMEGA = 146.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: ILE 8 - ILE 9 MODEL 6 OMEGA = 145.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: PRO 11 - HIS 12 MODEL 6 OMEGA = 234.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: HIS 12 - MET 13 MODEL 6 OMEGA = 145.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: LYS 17 - CYS 18 MODEL 6 OMEGA = 137.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: GLY 19 - LYS 20 MODEL 6 OMEGA = 236.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: LYS 20 - LYS 21 MODEL 6 OMEGA = 222.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: LEU 2 - CYS 3 MODEL 7 OMEGA = 214.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: ILE 8 - ILE 9 MODEL 7 OMEGA = 144.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: ILE 9 - ILE 10 MODEL 7 OMEGA = 211.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: PRO 11 - HIS 12 MODEL 7 OMEGA = 234.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: LYS 17 - CYS 18 MODEL 7 OMEGA = 130.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: GLY 19 - LYS 20 MODEL 7 OMEGA = 233.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
50: LYS 20 - LYS 21 MODEL 7 OMEGA = 240.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: LEU 2 - CYS 3 MODEL 8 OMEGA = 221.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: ASN 6 - ARG 7 MODEL 8 OMEGA = 147.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: ILE 8 - ILE 9 MODEL 8 OMEGA = 148.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: ILE 9 - ILE 10 MODEL 8 OMEGA = 217.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: PRO 11 - HIS 12 MODEL 8 OMEGA = 227.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: HIS 12 - MET 13 MODEL 8 OMEGA = 146.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: LYS 17 - CYS 18 MODEL 8 OMEGA = 141.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: GLY 19 - LYS 20 MODEL 8 OMEGA = 223.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: LYS 20 - LYS 21 MODEL 8 OMEGA = 148.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: LEU 2 - CYS 3 MODEL 9 OMEGA = 220.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: ILE 8 - ILE 9 MODEL 9 OMEGA = 143.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: ILE 9 - ILE 10 MODEL 9 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: PRO 11 - HIS 12 MODEL 9 OMEGA = 233.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: LYS 17 - CYS 18 MODEL 9 OMEGA = 146.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: GLY 19 - LYS 20 MODEL 9 OMEGA = 240.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: LYS 20 - LYS 21 MODEL 9 OMEGA = 224.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ARG 7 - ILE 8 MODEL 10 OMEGA = 213.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: ILE 9 - ILE 10 MODEL 10 OMEGA = 212.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: PRO 11 - HIS 12 MODEL 10 OMEGA = 229.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: HIS 12 - MET 13 MODEL 10 OMEGA = 142.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: LYS 17 - CYS 18 MODEL 10 OMEGA = 124.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: GLY 19 - LYS 20 MODEL 10 OMEGA = 232.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: LYS 20 - LYS 21 MODEL 10 OMEGA = 234.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: LEU 2 - CYS 3 MODEL 11 OMEGA = 222.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: CYS 3 - ASN 4 MODEL 11 OMEGA = 141.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: ASN 4 - CYS 5 MODEL 11 OMEGA = 148.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: ASN 6 - ARG 7 MODEL 11 OMEGA = 144.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: ILE 10 - PRO 11 MODEL 11 OMEGA = 147.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: PRO 11 - HIS 12 MODEL 11 OMEGA = 225.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: HIS 12 - MET 13 MODEL 11 OMEGA = 143.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: LYS 17 - CYS 18 MODEL 11 OMEGA = 136.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: GLY 19 - LYS 20 MODEL 11 OMEGA = 235.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: LYS 20 - LYS 21 MODEL 11 OMEGA = 231.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: LEU 2 - CYS 3 MODEL 12 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: ASN 6 - ARG 7 MODEL 12 OMEGA = 146.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: ILE 9 - ILE 10 MODEL 12 OMEGA = 210.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: PRO 11 - HIS 12 MODEL 12 OMEGA = 234.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: HIS 12 - MET 13 MODEL 12 OMEGA = 136.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: LYS 17 - CYS 18 MODEL 12 OMEGA = 142.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: GLY 19 - LYS 20 MODEL 12 OMEGA = 239.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
91: LYS 20 - LYS 21 MODEL 12 OMEGA = 223.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: ASN 6 - ARG 7 MODEL 13 OMEGA = 141.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: ILE 9 - ILE 10 MODEL 13 OMEGA = 212.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: PRO 11 - HIS 12 MODEL 13 OMEGA = 236.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: HIS 12 - MET 13 MODEL 13 OMEGA = 132.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: LYS 17 - CYS 18 MODEL 13 OMEGA = 132.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: GLY 19 - LYS 20 MODEL 13 OMEGA = 235.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: LYS 20 - LYS 21 MODEL 13 OMEGA = 228.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: ARG 7 - ILE 8 MODEL 14 OMEGA = 211.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: ILE 10 - PRO 11 MODEL 14 OMEGA = 148.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: PRO 11 - HIS 12 MODEL 14 OMEGA = 227.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: HIS 12 - MET 13 MODEL 14 OMEGA = 140.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: LYS 17 - CYS 18 MODEL 14 OMEGA = 131.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: CYS 18 - GLY 19 MODEL 14 OMEGA = 149.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: GLY 19 - LYS 20 MODEL 14 OMEGA = 242.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: LYS 20 - LYS 21 MODEL 14 OMEGA = 227.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
107: ILE 8 - ILE 9 MODEL 15 OMEGA = 144.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: ILE 9 - ILE 10 MODEL 15 OMEGA = 210.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: PRO 11 - HIS 12 MODEL 15 OMEGA = 229.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: HIS 12 - MET 13 MODEL 15 OMEGA = 146.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: LYS 17 - CYS 18 MODEL 15 OMEGA = 143.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: GLY 19 - LYS 20 MODEL 15 OMEGA = 240.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: LYS 20 - LYS 21 MODEL 15 OMEGA = 221.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: ILE 9 - ILE 10 MODEL 16 OMEGA = 222.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: PRO 11 - HIS 12 MODEL 16 OMEGA = 214.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: LYS 20 - LYS 21 MODEL 16 OMEGA = 149.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: ILE 9 - ILE 10 MODEL 17 OMEGA = 211.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: PRO 11 - HIS 12 MODEL 17 OMEGA = 214.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: LYS 17 - CYS 18 MODEL 17 OMEGA = 147.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: LYS 20 - LYS 21 MODEL 17 OMEGA = 148.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: ILE 9 - ILE 10 MODEL 18 OMEGA = 219.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: PRO 11 - HIS 12 MODEL 18 OMEGA = 225.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: LYS 17 - CYS 18 MODEL 18 OMEGA = 147.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: LYS 20 - LYS 21 MODEL 18 OMEGA = 142.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: LEU 2 - CYS 3 MODEL 19 OMEGA = 217.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: ILE 9 - ILE 10 MODEL 19 OMEGA = 221.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: PRO 11 - HIS 12 MODEL 19 OMEGA = 220.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: LYS 17 - CYS 18 MODEL 19 OMEGA = 144.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: LYS 20 - LYS 21 MODEL 19 OMEGA = 216.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: LEU 2 - CYS 3 MODEL 20 OMEGA = 211.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: PRO 11 - HIS 12 MODEL 20 OMEGA = 223.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: LYS 17 - CYS 18 MODEL 20 OMEGA = 141.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: LYS 20 - LYS 21 MODEL 20 OMEGA = 145.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: ASN 4 - CYS 5 MODEL 21 OMEGA = 147.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: ILE 9 - ILE 10 MODEL 21 OMEGA = 214.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: PRO 11 - HIS 12 MODEL 21 OMEGA = 220.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: LYS 17 - CYS 18 MODEL 21 OMEGA = 141.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
138: LYS 20 - LYS 21 MODEL 21 OMEGA = 135.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR アンサンブル
データ基準
コンフォーマー数 (登録 / 計算)21 / -
代表モデル

-
要素

#1: タンパク質・ペプチド TERTIAPIN


分子量: 2464.141 Da / 分子数: 1 / 由来タイプ: 組換発現
由来: (組換発現) Apis mellifera (セイヨウミツバチ)
参照: UniProt: P56587

-
実験情報

-
実験

実験手法: 溶液NMR

-
試料調製

結晶化
*PLUS
手法: other / 詳細: NMR

-
解析

NMRアンサンブル登録したコンフォーマーの数: 21

+
万見について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月：コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか？ / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例：em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見 (Yorodumi)

幾万の構造データを、幾万の視点から

  • 万見(Yorodumi)は、EMDB/PDB/SASBDBなどの構造データを閲覧するためのページです。
  • EM Navigatorの詳細ページの後継、Omokage検索のフロントエンドも兼ねています。

関連情報:EMDB / PDB / SASBDB / 3つのデータバンクの比較 / 万見検索 / 2016年8月31日: 新しいEM Navigatorと万見 / 万見文献 / Jmol/JSmol / 機能・相同性情報 / 新しいEM Navigatorと万見の変更点

他の情報も見る